INSIGHTS ON CLINICAL TRIAL DESIGN

• 4 Core Biomarker-Driven Study Designs In Oncology

  Modern oncology demands smarter trial designs. Explore how enrichment, stratification, and basket models transform biomarker data into successful, regulatory-ready clinical programs.

• Change Needed In Approach To Clinical Trials Patient Recruitment

  Drawing on real-world experience and end-to-end capabilities, this presentation outlines actionable strategies to accelerate recruitment, boost predictability, and expand patient trial access.

• Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier

  From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.

• Four Trends In Obesity Clinical Trials

  Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.

• The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting

  10/30/2024

  The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.

• Providing Access To Patients

  9/9/2025

  We believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.

• Leveraging Mobile Vision Clinics For Clinical Trial Exams

  3/11/2025

  Are you considering new options to improve your patient experience and expand your clinical trial's reach? 20/20 Onsite's mobile vision clinics provide a full optometry suite for all types of clinical trials.

• Biotech Landscape Continues To Shift

  9/18/2025

  Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.

• De-Risking The Neurology IND: Lessons From Early FDA Engagement

  5/27/2026

  Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.